These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 17521369)
1. The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response. Minne A; Louahed J; Mehauden S; Baras B; Renauld JC; Vanbever R Immunology; 2007 Nov; 122(3):316-25. PubMed ID: 17521369 [TBL] [Abstract][Full Text] [Related]
2. Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice. Trondsen M; Aqrawi LA; Zhou F; Pedersen G; Trieu MC; Zhou P; Cox RJ Scand J Immunol; 2015 May; 81(5):305-17. PubMed ID: 25737202 [TBL] [Abstract][Full Text] [Related]
3. Inactivated influenza vaccine adjuvanted with bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion. Keijzer C; Haijema BJ; Meijerhof T; Voorn P; de Haan A; Leenhouts K; van Roosmalen ML; van Eden W; Broere F Vaccine; 2014 May; 32(24):2904-10. PubMed ID: 24598720 [TBL] [Abstract][Full Text] [Related]
4. A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung. Neuhaus V; Chichester JA; Ebensen T; Schwarz K; Hartman CE; Shoji Y; Guzmán CA; Yusibov V; Sewald K; Braun A Vaccine; 2014 May; 32(26):3216-22. PubMed ID: 24731807 [TBL] [Abstract][Full Text] [Related]
5. H9N2 influenza whole inactivated virus combined with polyethyleneimine strongly enhances mucosal and systemic immunity after intranasal immunization in mice. Qin T; Yin Y; Huang L; Yu Q; Yang Q Clin Vaccine Immunol; 2015 Apr; 22(4):421-9. PubMed ID: 25673304 [TBL] [Abstract][Full Text] [Related]
6. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model. Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856 [TBL] [Abstract][Full Text] [Related]
7. Adjuvanted inactivated influenza A(H3N2) vaccines induce stronger immunogenicity in mice and confer higher protection in ferrets than unadjuvanted inactivated vaccines. Ann J; Samant M; Rheaume C; Dumas C; Beaulieu E; Morasse A; Mallett C; Hamelin ME; Papadopoulou B; Boivin G Vaccine; 2014 Sep; 32(43):5730-9. PubMed ID: 25173481 [TBL] [Abstract][Full Text] [Related]
8. Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses. Gallorini S; Taccone M; Bonci A; Nardelli F; Casini D; Bonificio A; Kommareddy S; Bertholet S; O'Hagan DT; Baudner BC Vaccine; 2014 Apr; 32(20):2382-8. PubMed ID: 24434044 [TBL] [Abstract][Full Text] [Related]
9. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration. de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989 [TBL] [Abstract][Full Text] [Related]
12. A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice. Joseph A; Itskovitz-Cooper N; Samira S; Flasterstein O; Eliyahu H; Simberg D; Goldwaser I; Barenholz Y; Kedar E Vaccine; 2006 May; 24(18):3990-4006. PubMed ID: 16516356 [TBL] [Abstract][Full Text] [Related]
13. Co-immunization with tandem repeat heterologous M2 extracellular proteins overcomes strain-specific protection of split vaccine against influenza A virus. Lee YN; Kim MC; Lee YT; Kim YJ; Lee J; Kim C; Ha SH; Kang SM Antiviral Res; 2015 Oct; 122():82-90. PubMed ID: 26248203 [TBL] [Abstract][Full Text] [Related]
14. Route of administration is the prime determinant of IgA and IgG2a responses in the respiratory tract of mice to the cold-adapted live attenuated influenza A donor strain A/Leningrad/134/17/57. Wareing MD; Tannock GA Vaccine; 2003 Jul; 21(23):3097-100. PubMed ID: 12804835 [TBL] [Abstract][Full Text] [Related]
15. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice. Wack A; Baudner BC; Hilbert AK; Manini I; Nuti S; Tavarini S; Scheffczik H; Ugozzoli M; Singh M; Kazzaz J; Montomoli E; Del Giudice G; Rappuoli R; O'Hagan DT Vaccine; 2008 Jan; 26(4):552-61. PubMed ID: 18162266 [TBL] [Abstract][Full Text] [Related]
16. Comparative antibody responses and protection in mice immunised by oral or parenteral routes with influenza virus subunit antigens in aqueous form or incorporated into ISCOMs. Ghazi HO; Potter CW; Smith TL; Jennings R J Med Microbiol; 1995 Jan; 42(1):53-61. PubMed ID: 7739026 [TBL] [Abstract][Full Text] [Related]
17. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of mucosal and systemic immune responses elicited by GPI-0100- adjuvanted influenza vaccine delivered by different immunization strategies. Liu H; Patil HP; de Vries-Idema J; Wilschut J; Huckriede A PLoS One; 2013; 8(7):e69649. PubMed ID: 23936066 [TBL] [Abstract][Full Text] [Related]
19. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection. Hong SH; Byun YH; Nguyen CT; Kim SY; Seong BL; Park S; Woo GJ; Yoon Y; Koh JT; Fujihashi K; Rhee JH; Lee SE Vaccine; 2012 Jan; 30(2):466-74. PubMed ID: 22051136 [TBL] [Abstract][Full Text] [Related]
20. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses. Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]